Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa
Microbiology Spectrum · 15.06.2023 · 11 (3)
DOI: 10.1128/spectrum.00932-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 15.06.2023. Verfasst von Leilei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Ceftazidime, Pseudomonas Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Science and Technology Commission, MOST | National Natural Science Foundation of China.
Abstract (Originalsprache)
The emergence of antimicrobial resistance poses a particular challenge globally, and the concept of P. aeruginosa with “difficult-to-treat” resistance (DTR- P. aeruginosa ) was proposed. Here, P. aeruginosa clinical isolates were highly susceptible to three β-lactamase inhibitor combinations, CZA, IMR, and ceftolozane-tazobactam.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
- Key Laboratory of Clinical Pharmacology of Antibiotics, National Heath Commission of People's Republic of China, Shanghai, China.
ORCID-Profile: Fan Yang, Qinglan Guo, Minggui Wang
Förderung
- Shanghai Municipal Science and Technology Commission
- MOST | National Natural Science Foundation of China
Zitieren
APA
Wang, L., Zhang, X., Zhou, X., Yang, F., Guo, Q., & Wang, M. (2023). Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa. Microbiology Spectrum, 11(3). https://doi.org/10.1128/spectrum.00932-23
Vancouver
Wang L, Zhang X, Zhou X, Yang F, Guo Q, Wang M. Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa. Microbiology Spectrum. 2023;11(3). doi:10.1128/spectrum.00932-23
BibTeX
@article{Wang2023,
author = {Wang, Leilei and Zhang, Xuefei and Zhou, Xun and Yang, Fan and Guo, Qinglan and Wang, Minggui},
title = {Comparison of In Vitro Activity of Ceftazidime-Avibactam and Imipenem-Relebactam against Clinical Isolates of Pseudomonas aeruginosa},
journal = {Microbiology Spectrum},
year = {2023},
volume = {11},
number = {3},
doi = {10.1128/spectrum.00932-23}
}
EUVIMED